Joshua Wolf, M.D.
Surgeon, Division of Colon and Rectal Surgery
Associate Program Director, General Surgery Residency
Dr. Joshua Wolf felt called to come back to Baltimore when he finished his medical training and now offers care for patients in the greater Park Heights area, which sees some of the city’s poorest health outcomes.
“Helping patients understand the diagnosis and treatment options is just as important as actually performing their surgery, and I am humbled that patients trust me to do both,” Wolf said.
In 2018, Wolf was named a Top Doctor by Baltimore magazine, and at Johns Hopkins, where he was an intern and a resident, he received the Anthony L. Imbembo Resident Teaching Award from the Department of Surgery.
Wolf is a colorectal surgeon at Sinai Hospital, which is a nonprofit teaching hospital that provides training for more than 140 residents and 400 medical students yearly.
He has made it a priority to help those young doctors and students avoid stress and burnout and connect with patients. For instance, he started a research project that seeks to integrate exercise and social connection in resident life at Sinai. Residents can access an app, BurnAlong, that provides on-demand individual and group exercise videos.
He also has worked to develop the “Back to Bedside” program with the Accreditation Council for Graduate Medical Education. He serves on the committee that oversees its grant program, which funded 30 out of 240 applications in its first funding cycle. Those projects will help find creative ideas to help new doctors maintain their sense of purpose and motivation during the pressures of residency.
Wolf graduated from Yale University and completed his medical degree at New York University School of Medicine. He completed a fellowship and was a clinical associate at the Cleveland Clinic Florida, where he worked with renowned surgeon Dr. Steven Wexner.
As a result of that opportunity, Wolf also developed an interest in research and is currently involved in research at Sinai Hospital on innovative solutions for screening for rectal and anal cancer in high-risk patients.